- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Prolonged oxytocin exposure during birth increases risk of obstetric hemorrhage: Study
Boston, MA: Prolonged exposure to intrapartum exogenous oxytocin is associated with an increased risk of obstetric hemorrhage (OBH) and increased quantitative blood loss (QBL), says research published in the journal Obstetrics & Gynecology.
There is no clear understanding of the relationship between the duration of intrapartum oxytocin exposure and OBH. The use of estimated, not quantitative, blood loss data was the limiting factor for the prior studies. Megan Alexander, Boston University School of Medicine, Boston, MA, and colleagues, therefore, aimed to assess whether the prolonged duration of intrapartum Pitocin exposure is associated with 1) increased quantitative blood loss (QBL), 2) OBH (QBL greater than or equal to 1,000 mL), or 3) hemorrhage-related maternal morbidity.
For this purpose, the researchers performed a retrospective cohort analysis of all who were exposed to intrapartum exogenous oxytocin for induction or augmentation from January 1, 2018, to December 31, 2019. Women were divided by hours of intrapartum oxytocin exposure: <12 hours or ≥12 hours of exposure. t-test and chi-square test were used to make comparisons between the groups.
The findings of the study were as follows:
- Of 5,332 patients, 2,232 (41.9%) had intrapartum oxytocin exposure.
- Compared to patients with intrapartum oxytocin exposure <12 hours, those with ≥12 hours had higher mean QBL and higher probability of OBH.
- Oxytocin exposure of ≥12 hours was not associated with increased hemorrhage-related morbidity.
Co-investigator Ashley Comfort of Boston Medical Center said it was significant that patients who had a longer exposure to oxytocin and went on to have a C-section did not face an increased hemorrhage risk. In the context of high rates of C-section deliveries, as well as an effort to decrease these rates, more data on the risk of obstetric interventions by mode of delivery is critical to help clinicians make informed choices.
"Prolonged exposure to oxytocin during birth, in particular >12 hours, was associated with increased QBL and increased probability of OBH," wrote the authors. "Future studies should additionally explore the impact of rate and dose of oxytocin on the risk of obstetric hemorrhage."
Reference:
Alexander, Megan MS; Wang, Michelle MD; Srivastava, Akanksha BS; Tummala, Swetha P. BS; Abbas, Diana S. BS; Comfort, Ashley MD Prolonged Duration of Oxytocin Exposure Increases Obstetric Hemorrhage Risk [A135], Obstetrics & Gynecology: May 2022 - Volume 139 - Issue - p 39S-40S doi: 10.1097/01.AOG.0000825820.92319.9e
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751